February 9, 2018
Gilead Sciences’ once-daily single tablet regimen (STR), Biktarvy® received the US FDA approval for the treatment of HIV-1 infection in ...
Access articles & resources worth up to US $4, 000 per month.
Most up-to-date information, original and in-depth reviews, full-length exclusive market reports and forecasts, full-access to the smart knowledge base centres, useful resources and databases.
Access articles & resources worth up to $4000.
First Oral Drug Reducing Risk of Blood Loss in Liver Disease Patients Gets Approved
First Migraine-Preventing Drug ‘Aimovig’ Bags FDA Approval
First Drug to Treat Polycystic Kidney Disease Bags FDA Approval
Drug Innovation: FDA Approves Seven New Drugs in Four Months (Jan-Apr 2018)
7 New Ideas to Start a Healthcare Business in India (2018)
Pharma Patents: Can India Reward Incremental Innovation?